Marshall Mazepa

Marshall Mazepa, Assistant Professor of Medicine at the University of Minnesota and TTP expert, shares crucial insights into thrombotic thrombocytopenic purpura. He discusses the importance of understanding TTP for timely diagnosis and the role of caplacizumab in treatment. The conversation also covers chronic complications like stroke and cognitive issues in survivors, the unpredictability of relapse, and the potential benefits of repeat ADAMTS13 testing. Finally, Mazepa outlines future directions for tailored therapies and the need for ongoing patient engagement in research.